Syngulon and Eppen sign a MOU for the development of a new generation...

Eppen and Syngulon have signed a MOU (Memorandum of Understanding) for the development of a new generation of feed probiotics leveraging bacteriocins as a natural alternative to antibiotics to enhance...(PRWeb November 21, 2019)Read the full story at https://www.prweb.com/releases/syngulon_and_eppen_sign_a_mou_for_the_development_of_a_new_generation_of_feed_probiotics_leveraging_bacteriocins_as_a_natural_alternative_to_antibiotics/prweb16736756.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news